Roche Products (India) Pvt. Ltd

Last updated: 13.02.2014

Address: ‘The View’, 2nd Floor,
165, Dr. Annie Besant Road
Worli, Mumbai 400 018,India

Tel: +91-22-24941414

Web: http://www.rocheindia.com/

Company description

In November 1957, F. Hoffmann-La Roche Ltd. (FHLR), Basle, finalised negotiations with the Government of India for the local manufacture of synthetic Vitamin A and pharmaceutical specialties in line with the Indian Government’s policy of industrialisation.

The activities of Roche in India commenced with the import of finished pharmaceutical products and bulk vitamins by Volkart Brothers and subsequently by Voltas Ltd. Later the manufacture of two pharmaceutical specialties -SARIDON® and SIROLIN® commenced after an Indian Roche entity was incorporated on 1st April, 1958.

Roche Products (India) Pvt. Ltd. (formerly known as Roche Scientific Company (India) Pvt. Ltd.) was incorporated in India in April, 1994 and is an affiliate of FHLR.

Products and services

FHLR initially appointed Nicholas Piramal India Ltd. (NPIL) in 1994 as authorised Distributor in India for some products of Roche. However, thereafter FHRL has appointed a new Distributor in India viz. Taksal Pharma Pvt. Ltd. (Taksal) for distribution of FHLR products in India since 2003,

Presently, Roche Products (India) Pvt. Ltd. is involved in marketing and scientific promotion of Roche’s products (including its strong biotech range) in India such as Herceptin® Mabthera® AvastinTM Pegasys® Mircera® Actemra® Valcyte® Xeloda® Tarceva® NeoRecormon® Neulastim® Neupogen® Roferon-A®, Bondronat® Cellcept® Invirase® for which Taksal Pharma Pvt. Ltd. is the authorised Importer and Distributor of FHLR in India. In addition, Xenical is imported, distributed and marketed in India by USV Limited.

Roche Products (India) Pvt. Ltd. is also actively involved in monitoring and support of various clinical trials in the field of Oncology, Nephrology, Rheumatology and Virology.

FLHR has also given perpetual license to Piramal Healthcare Limited (PHL) to use its trademarks in India such as Bactrim®, Lariam®, Valium® Madopar®, Rocaltrol®, Rivotril® and Euglucon®. Additionally, FHLR has also transferred and assigned its trademarks in India to PHL such as Dispeptal®, Ismo®, Librax®, Librium®, Mittavin®, Paraxin® and Bezalip®.

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here